Elena Crisa

Candiolo, 10060, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

Journal: Cancers
Published: April 08, 2026

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

Journal: European journal of haematology
Published: February 24, 2026

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

Journal: Cancer
Published: February 19, 2026

An Italian cartography of VEXAS-related thrombosis.

An Italian cartography of VEXAS-related thrombosis.

Journal: HemaSphere
Published: January 17, 2026

Effects of lactoferrin-enriched dairy product on iron status in women with gestational diabetes mellitus.

Effects of lactoferrin-enriched dairy product on iron status in women with gestational diabetes mellitus.

Journal: NPJ science of food
Published: January 14, 2026

Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation.

Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation.

Journal: Frontiers in oncology
Published: November 14, 2025

Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Journal: Cancers
Published: July 16, 2025

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Journal: Cancers
Published: March 28, 2025

Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.

Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.

Journal: British journal of haematology
Published: September 17, 2024

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Journal: Leukemia
Published: April 12, 2024

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

Journal: European journal of haematology
Published: March 11, 2024

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

Journal: Blood advances
Published: December 21, 2023
Showing 1-12 of 52

Last Updated: 09/26/2026